ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced that the Company will present at the UBS Global Life Sciences Conference on Wednesday, September 23rd at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) at the Grand Hyatt New York in New York City. The UBS Global Life Sciences Conference attracts the largest and most influential companies in the life sciences sector and provides participating companies with the opportunity to present to top institutional investors.
